H.I.G. Capital News
-
January 2, 2019 - Intact Vascular Announces Enrollment Completion of TOBA II BTK Clinical
WAYNE, PA - January 2, 2019 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced its Tack Optimized
-
December 18, 2018 - Apollo Endosurgery, Inc. Announces the Sale of Its Surgical Product Line
AUSTIN, TX - December 18, 2018 - Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced the sale of its Surgical product line, which consists of the Lap-Band® adjustable…
-
November 29, 2018 - CardioFocus Completes Enrollment In HeartLight® X3 Trial
MARLBOROUGH, MA – November 29, 2018 - CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced completed enrollment in a trial to evaluate its next-generation HeartLight® X3 Endoscopic Ablation System. A…
-
AUSTIN, TX - November 27, 2018 - Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the first commercial shipments of the OverStitch™ Sx Endoscopic Suturing System.…
-
CARLSBAD, CA. - November 20, 2018 - Vertiflex® Inc., a leading innovator of advanced, minimally invasive interventions for spinal stenosis, announced additional results from a randomized, controlled trial of its Superion® Indirect Decompression System in patients with lumbar spinal…
-
November 6, 2018 - Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial
WAYNE, PA - November 6, 2018 – Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced at the 15th annual VIVA conference in Las Vegas that its Tack Optimized Balloon Angioplasty II (TOBA II) clinical trial successfully…
-
November 5, 2018 - Intact Vascular Hires Industry Veteran Steve MacKinnon as Vice President of Sales
WAYNE, PA - November 5, 2018 – Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that Steve MacKinnon has joined its senior management team as Vice President of Sales, effective immediately. Reporting to the…
-
WEST LAFAYETTE, IN - October 15, 2018 - On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-targeted fluorescent dyes to improve cancer surgery, announced today the publication of a study evaluating the effectiveness of On Target Laboratories'…
-
MIAMI – October 11, 2018 - H.I.G. BioHealth Partners (“H.I.G.”), the dedicated healthcare investment affiliate of H.I.G. Capital, a leading global private equity investment firm with over $27 billion of equity capital under management,* recently announced the sale of HyperBranch…
-
WAYNE, PA – August 6 , 2018 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced key presentations that will be featured during a CME symposium at the Amputation Prevention (AMP) Conference in Chicago on August…
-
July 11, 2018 - CardioFocus® Announces Full Commercial Launch of HeartLight® System in Japan
MARLBOROUGH, MA – July 11, 2018 - CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for atrial fibrillation (AF), today announced the commercial launch of its HeartLight Endoscopic Ablation System in Japan. The commercial launch…
-
WAYNE, PA – July 11 , 2018 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today welcomed the publication of the iDissection Classification trial results in the current issue of Journal of Invasive Cardiology. Post-percutaneous…
-
DURHAM, NC - June 11, 2018 - HyperBranch Medical Technology, Inc. announced today that on June 8, 2018, after a two-week trial in federal district court in Wilmington, Delaware, an 8-member jury found in favor of HyperBranch on all remaining claims and legal defenses at issue in a patent…
-
AUSTIN – May 8, 2018 - Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the establishment of a multicenter, longitudinal, data repository for Endoscopic Sleeve Gastroplasty…
-
MARLBOROUGH, MA – May 7, 2018 - CardioFocus, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted approval for the HeartLight Excalibur Balloon, a next-generation technology designed for the treatment of paroxysmal atrial fibrillation (PAF)*. The Excalibur…
-
AUSTIN - April 23, 2018 - Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Saudi Food and Drug Authority (SFDA) has approved the ORBERA365™ Managed Weight…
-
WAYNE, PA – April 16, 2018 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it closed a Series C financing totaling $20 million. This financing is designed to fund the Company through Pre-Market Approval…
-
WAYNE, PA – April 16, 2018 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized…
-
WEST LAFAYETTE, IN - April 5, 2018 – On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-targeted fluorescent dyes to improve cancer surgery, announced today that the first patient was treated in a Phase 3 clinical trial of OTL38 in the detection…
-
WAYNE, PA – March 27, 2018 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today welcomed the publication of the Tack Optimized Balloon Angioplasty Below the Knee (TOBA BTK) clinical trial results in the current issue…
-
WEST LAFAYETTE, IN - March 14, 2018 – On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-targeted fluorescent dyes to improve cancer surgery, has secured an additional financing as part of its Series B capital raise which initially closed…
-
February 26, 2018 - CardioFocus Announces Initiation of HeartLight® X3 Clinical Evaluation
MARLBOROUGH, MA – February 26, 2018 - CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced the initiation of a clinical evaluation of the new HeartLight X3 System…
-
WAYNE, PA – January 25, 2018 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the Tack Optimized…